Bayer Wins Roundup Cancer Trial After Supreme Court Ruling

Summary

Bayer, the German pharmaceutical giant, secured a unanimous victory in a Missouri jury trial over claims that its Roundup weedkiller caused cancer in three women. The case follows a U.S. Supreme Court decision that narrowed the scope of Roundup lawsuits.

Trial Details

• Case: Theresa Aretino, Cynthia Fernandez, and Betty Larkin vs. Bayer (through Monsanto) – 2020 filing.
• Outcome: Jury found no evidence of design defect, fraud, or negligence.
• Significance: First trial win since the Supreme Court’s *Durnell* ruling, which limited plaintiffs’ ability to argue that the product’s label failed to warn about cancer risk.

Broader Legal Context

• Bayer is awaiting a separate court decision on a $7.25 billion settlement request related to tens of thousands of other Roundup cases.
• The Supreme Court held that the Environmental Protection Agency (EPA) determined the label did not require a cancer warning, thereby restricting certain claims.

Company Response

Bill Dodero, Bayer’s U.S. general counsel, stated:

"The verdict confirms there is no evidence of design defect, fraud, or negligence in the Roundup litigation. Plaintiffs will face significant challenges in proving viable claims after the Durnell ruling."

Scientific Background

• Glyphosate, the active ingredient in Roundup, is described by Bayer as "one of the most studied agricultural tools in history."
• The EPA has previously concluded glyphosate is probably not carcinogenic, though a new safety review is underway.
• The International Agency for Research on Cancer (IARC) classified glyphosate as "probably carcinogenic to humans" in 2015; Bayer disputes this assessment.

Practical Implications

• The Missouri verdict may influence future litigation strategies and settlement negotiations.
• Consumers and farmers should stay informed about ongoing regulatory reviews and potential changes to product labeling.

How to Verify

• Check the official Missouri court docket for the case number and verdict details.
• Review the U.S. Supreme Court’s *Durnell* decision for legal precedent.
• Follow updates from the EPA and IARC regarding glyphosate safety.

Key Takeaways

• Bayer’s win underscores the legal challenges plaintiffs face after the Supreme Court ruling.
• The outcome does not settle the broader debate over glyphosate’s safety.
• Ongoing litigation and regulatory reviews will continue to shape the future of Roundup and similar products.